10 results
10-K
2020 FY
RPTX
Repare Therapeutics Inc
4 Mar 21
Annual report
5:25pm
a sustainable and long-term pipeline of novel product candidates for the targeted treatment of cancers with high unmet medical need.
Opportunistically
424B4
RPTX
Repare Therapeutics Inc
19 Jun 20
Prospectus supplement with pricing info
4:38pm
the addressable patient populations for each of our product candidates. We believe our approach will allow us to continue to build a sustainable … for each of our product candidates. We believe our approach will allow us to continue to build a sustainable and long-term pipeline of novel product
S-1/A
qkb213az8
15 Jun 20
IPO registration (amended)
6:18am
S-1
phbbac3epz
29 May 20
IPO registration
5:26pm
DRS/A
484lf ejn
12 May 20
Draft registration statement (amended)
12:00am
DRS
cze8hmip6
6 Apr 20
Draft registration statement
12:00am
- Prev
- 1
- Next